FOXM1 and cancer: FOXM1 shares this low-duplicability feature with many cancer genes, which have been shown to possess a significantly lower chance to duplicate when compared to non-cancer genes [57]: the delicate pro-oncogenic nature of cancer genes likely poses a constraint to any change in their copy number and dosage, keeping cancer genes as evolutionary soloists.